The global Contract Pharmaceutical Manufacturing market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Contract Pharmaceutical Manufacturing market based on company, product type, end user and key regions.
This report studies the global market size of Contract Pharmaceutical Manufacturing in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Contract Pharmaceutical Manufacturing in these regions.
This research report categorizes the global Contract Pharmaceutical Manufacturing market by top players/brands, region, type and end user. This report also studies the global Contract Pharmaceutical Manufacturing market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Catalent
DPx
Lonza
Piramal Healthcare
Aenova
Jubilant
Famar
Boehringer Ingelheim
Fareva Holding
AbbVie
Nipro Corp
Vetter
Sopharma
DPT Laboratories
Recipharm
NextPharma
Dishman
Aesica
Market size by Product
Active Pharmaceutical Ingredients (API)
Finished Dosage Formulations (FDF)
Market size by End User
Big Pharma
Specialty/Midsize
Generics
Other
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Contract Pharmaceutical Manufacturing market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Contract Pharmaceutical Manufacturing market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Contract Pharmaceutical Manufacturing companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Contract Pharmaceutical Manufacturing submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Contract Pharmaceutical Manufacturing are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Pcs). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Contract Pharmaceutical Manufacturing market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
1.1 Contract Pharmaceutical Manufacturing Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Contract Pharmaceutical Manufacturing Market Size Growth Rate by Product
1.4.2 Active Pharmaceutical Ingredients (API)
1.4.3 Finished Dosage Formulations (FDF)
1.5 Market by End User
1.5.1 Global Contract Pharmaceutical Manufacturing Market Size Growth Rate by End User
1.5.2 Big Pharma
1.5.3 Specialty/Midsize
1.5.4 Generics
1.5.5 Other
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Contract Pharmaceutical Manufacturing Market Size
2.1.1 Global Contract Pharmaceutical Manufacturing Revenue 2014-2025
2.1.2 Global Contract Pharmaceutical Manufacturing Sales 2014-2025
2.2 Contract Pharmaceutical Manufacturing Growth Rate by Regions
2.2.1 Global Contract Pharmaceutical Manufacturing Sales by Regions
2.2.2 Global Contract Pharmaceutical Manufacturing Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Contract Pharmaceutical Manufacturing Sales by Manufacturers
3.1.1 Contract Pharmaceutical Manufacturing Sales by Manufacturers
3.1.2 Contract Pharmaceutical Manufacturing Sales Market Share by Manufacturers
3.1.3 Global Contract Pharmaceutical Manufacturing Market Concentration Ratio (CR5 and HHI)
3.2 Contract Pharmaceutical Manufacturing Revenue by Manufacturers
3.2.1 Contract Pharmaceutical Manufacturing Revenue by Manufacturers (2014-2019)
3.2.2 Contract Pharmaceutical Manufacturing Revenue Share by Manufacturers (2014-2019)
3.3 Contract Pharmaceutical Manufacturing Price by Manufacturers
3.4 Contract Pharmaceutical Manufacturing Manufacturing Base Distribution, Product Types
3.4.1 Contract Pharmaceutical Manufacturing Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Contract Pharmaceutical Manufacturing Product Type
3.4.3 Date of International Manufacturers Enter into Contract Pharmaceutical Manufacturing Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Contract Pharmaceutical Manufacturing Sales by Product
4.2 Global Contract Pharmaceutical Manufacturing Revenue by Product
4.3 Contract Pharmaceutical Manufacturing Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Contract Pharmaceutical Manufacturing Breakdown Data by End User
6 North America
6.1 North America Contract Pharmaceutical Manufacturing by Countries
6.1.1 North America Contract Pharmaceutical Manufacturing Sales by Countries
6.1.2 North America Contract Pharmaceutical Manufacturing Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Contract Pharmaceutical Manufacturing by Product
6.3 North America Contract Pharmaceutical Manufacturing by End User
7 Europe
7.1 Europe Contract Pharmaceutical Manufacturing by Countries
7.1.1 Europe Contract Pharmaceutical Manufacturing Sales by Countries
7.1.2 Europe Contract Pharmaceutical Manufacturing Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Contract Pharmaceutical Manufacturing by Product
7.3 Europe Contract Pharmaceutical Manufacturing by End User
8 Asia Pacific
8.1 Asia Pacific Contract Pharmaceutical Manufacturing by Countries
8.1.1 Asia Pacific Contract Pharmaceutical Manufacturing Sales by Countries
8.1.2 Asia Pacific Contract Pharmaceutical Manufacturing Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Contract Pharmaceutical Manufacturing by Product
8.3 Asia Pacific Contract Pharmaceutical Manufacturing by End User
9 Central & South America
9.1 Central & South America Contract Pharmaceutical Manufacturing by Countries
9.1.1 Central & South America Contract Pharmaceutical Manufacturing Sales by Countries
9.1.2 Central & South America Contract Pharmaceutical Manufacturing Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Contract Pharmaceutical Manufacturing by Product
9.3 Central & South America Contract Pharmaceutical Manufacturing by End User
10 Middle East and Africa
10.1 Middle East and Africa Contract Pharmaceutical Manufacturing by Countries
10.1.1 Middle East and Africa Contract Pharmaceutical Manufacturing Sales by Countries
10.1.2 Middle East and Africa Contract Pharmaceutical Manufacturing Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Contract Pharmaceutical Manufacturing by Product
10.3 Middle East and Africa Contract Pharmaceutical Manufacturing by End User
11 Company Profiles
11.1 Catalent
11.1.1 Catalent Company Details
11.1.2 Company Business Overview
11.1.3 Catalent Contract Pharmaceutical Manufacturing Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Catalent Contract Pharmaceutical Manufacturing Products Offered
11.1.5 Catalent Recent Development
11.2 DPx
11.2.1 DPx Company Details
11.2.2 Company Business Overview
11.2.3 DPx Contract Pharmaceutical Manufacturing Sales, Revenue and Gross Margin (2014-2019)
11.2.4 DPx Contract Pharmaceutical Manufacturing Products Offered
11.2.5 DPx Recent Development
11.3 Lonza
11.3.1 Lonza Company Details
11.3.2 Company Business Overview
11.3.3 Lonza Contract Pharmaceutical Manufacturing Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Lonza Contract Pharmaceutical Manufacturing Products Offered
11.3.5 Lonza Recent Development
11.4 Piramal Healthcare
11.4.1 Piramal Healthcare Company Details
11.4.2 Company Business Overview
11.4.3 Piramal Healthcare Contract Pharmaceutical Manufacturing Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Piramal Healthcare Contract Pharmaceutical Manufacturing Products Offered
11.4.5 Piramal Healthcare Recent Development
11.5 Aenova
11.5.1 Aenova Company Details
11.5.2 Company Business Overview
11.5.3 Aenova Contract Pharmaceutical Manufacturing Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Aenova Contract Pharmaceutical Manufacturing Products Offered
11.5.5 Aenova Recent Development
11.6 Jubilant
11.6.1 Jubilant Company Details
11.6.2 Company Business Overview
11.6.3 Jubilant Contract Pharmaceutical Manufacturing Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Jubilant Contract Pharmaceutical Manufacturing Products Offered
11.6.5 Jubilant Recent Development
11.7 Famar
11.7.1 Famar Company Details
11.7.2 Company Business Overview
11.7.3 Famar Contract Pharmaceutical Manufacturing Sales, Revenue and Gross Margin (2014-2019)
11.7.4 Famar Contract Pharmaceutical Manufacturing Products Offered
11.7.5 Famar Recent Development
11.8 Boehringer Ingelheim
11.8.1 Boehringer Ingelheim Company Details
11.8.2 Company Business Overview
11.8.3 Boehringer Ingelheim Contract Pharmaceutical Manufacturing Sales, Revenue and Gross Margin (2014-2019)
11.8.4 Boehringer Ingelheim Contract Pharmaceutical Manufacturing Products Offered
11.8.5 Boehringer Ingelheim Recent Development
11.9 Fareva Holding
11.9.1 Fareva Holding Company Details
11.9.2 Company Business Overview
11.9.3 Fareva Holding Contract Pharmaceutical Manufacturing Sales, Revenue and Gross Margin (2014-2019)
11.9.4 Fareva Holding Contract Pharmaceutical Manufacturing Products Offered
11.9.5 Fareva Holding Recent Development
11.10 AbbVie
11.10.1 AbbVie Company Details
11.10.2 Company Business Overview
11.10.3 AbbVie Contract Pharmaceutical Manufacturing Sales, Revenue and Gross Margin (2014-2019)
11.10.4 AbbVie Contract Pharmaceutical Manufacturing Products Offered
11.10.5 AbbVie Recent Development
11.11 Nipro Corp
11.12 Vetter
11.13 Sopharma
11.14 DPT Laboratories
11.15 Recipharm
11.16 NextPharma
11.17 Dishman
11.18 Aesica
12 Future Forecast
12.1 Contract Pharmaceutical Manufacturing Market Forecast by Regions
12.1.1 Global Contract Pharmaceutical Manufacturing Sales Forecast by Regions 2019-2025
12.1.2 Global Contract Pharmaceutical Manufacturing Revenue Forecast by Regions 2019-2025
12.2 Contract Pharmaceutical Manufacturing Market Forecast by Product
12.2.1 Global Contract Pharmaceutical Manufacturing Sales Forecast by Product 2019-2025
12.2.2 Global Contract Pharmaceutical Manufacturing Revenue Forecast by Product 2019-2025
12.3 Contract Pharmaceutical Manufacturing Market Forecast by End User
12.4 North America Contract Pharmaceutical Manufacturing Forecast
12.5 Europe Contract Pharmaceutical Manufacturing Forecast
12.6 Asia Pacific Contract Pharmaceutical Manufacturing Forecast
12.7 Central & South America Contract Pharmaceutical Manufacturing Forecast
12.8 Middle East and Africa Contract Pharmaceutical Manufacturing Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Contract Pharmaceutical Manufacturing Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
